KAPVAY
Live / Registered — Registered and renewed (as of 04 Dec 2023)
What this means for you
Registered since 09 Jul 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Jul 2023).
Record
- Serial number
- 77864611
- Registration number
- 4365005
- Mark type
- Stylized text
- Filed
- 04 Nov 2009
- Published for opposition
- 02 Mar 2010
- Registered
- 09 Jul 2013
- Next maintenance due
- 09 Jul 2023
- Attorney of record
- Julie Beth Albert
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, in the form of an extended release oral dosage for the treatment of attention deficit hyperactivity disorders and other disorders characterized by excessive autonomic hyperactivity
Owner
- CONCORDIA PHARMACEUTICALS INC., Grand Duchy, LU
- CONCORDIA PHARMACEUTICALS INC., BRIDGETOWN, BB, BB
- CONCORDIA PHARMACEUTICALS INC., BRIDGETOWN, BB, BB
- SHIONOGI INC., FLORHAM PARK, NJ, US
- SHIONOGI PHARMA, INC., ATLANTA, GA, US
- Sciele Pharma, Inc., Atlanta, GA, US
- Sciele Pharma, Inc., Atlanta, GA, US
Prosecution history
- 14 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Dec 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Dec 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Dec 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 Dec 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Dec 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Dec 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 04 Dec 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Dec 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Jun 2023 — TEAS SECTION 8 & 9 RECEIVED
- 09 Jul 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Jun 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 18 Mar 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Mar 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Mar 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED